A longitudinal cohort to monitor malaria infection incidence during mass drug administration in Southern Province, Zambia

American Journal of Tropical Medicine and Hygiene

Volumn 103, Issue 2, 2020, Pages 54-65

  Bennett, Adam ^a   Porter, Travis R ^b   Mwenda, Mulenga C ^c   Yukich, Joshua O ^b   Finn, Timothy P ^b   Lungu, Chris ^c   Silumbe, Kafula ^c   Mambwe, Brenda ^c   Chishimba, Sandra ^c   Mulube, Conceptor ^c   Bridges, Daniel J ^c   Hamainza, Busiku ^d   Slutsker, Laurence ^e   Steketee, Richard W ^e   Miller, John M ^c   Eisele, Thomas P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE UNIVERSITY   (United States)

^c Malaria Control and Evaluation Partnership in Africa (MACEPA)   (Zambia)

^d MINISTRY OF HEALTH   (Zambia)

^e PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE MANAGEMENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; GLOBAL POSITIONING SYSTEM; HOUSEHOLD; HUMAN; INDOOR RESIDUAL SPRAYING; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; MASS DRUG ADMINISTRATION; MORBIDITY; POLYMERASE CHAIN REACTION; RISK REDUCTION; RURAL POPULATION; SEASONAL VARIATION; VECTOR CONTROL; ZAMBIA; COMBINATION DRUG THERAPY; DISEASE ERADICATION; FAMILY SIZE; INCIDENCE; MALARIA FALCIPARUM; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADOLESCENT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; DRUG THERAPY, COMBINATION; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; QUINOLINES; YOUNG ADULT; ZAMBIA;

EID: 85089302159     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.19-0657     Document Type: Article

References (22)

1. Miller JM, Eisele TP, Fraser MS, Lewis MT, Slutsker L, Chizema Kawesha E, 2020. Moving from malaria burden reduction toward elimination: an evaluation of mass drug administration in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 3-6.
2. Eisele TP et al., 2015. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 16: 347.
3. Von Seidlein L et al., 2003. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in the Gambia. Trans R Soc Trop Med Hyg 97: 217-225.
4. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J, 2013. Mass drug administration for malaria. Cochrane Database Syst Rev 12: CD008846.
5. Mwesigwa L et al., 2019. Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in the Gambia: a prospective cohort study. Clin Infect Dis 69: 278-286.
6. Yukich J, Briet O, Bretscher MT, Bennet A, Lemma S, Berhane Y, Eisele TP, Keating J, Smith T, 2012. Estimating Plasmodium falciparum transmission rates in low-endemic settings using a combination of community prevalence and health facility data. PLoS One 7: e42861.
7. Hay SI, Smith DL, Snow RW, 2008. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8: 369-378.
8. Eisele TP et al., 2020. Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 7-18.
9. WHO, 2017. Mass Drug Administration for Falciparum Malaria: a Practical Field Manual. Geneva, Switzerland: World Health Organization.
10. Eisele TP et al., 2016. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis 214: 1831-1839.
11. Funk C. et al., 2015. The climate hazards infrared precipitation with stations-a new environmental record for monitoring extremes. Sci Data 2: 150066.
12. Cook J, Owaga C, Marube E, Baidjoe A, Stresman G, Migiro R, Cox J, Drakeley C, Stevenson JC, 2018. Risk factors for Plasmodium falciparum infection in the Kenyan Highlands: a cohort study. Trans R Soc Trop Med Hyg 1-8.
13. Chishimba S et al., 2020. Prevalence of Plasmodium falciparum and non-falciparum infections by photo-induced electron transfer-PCR in a longitudinal cohort of individuals enrolled in a mass drug administration trial in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 82-89.
14. Das S et al., 2017. Performance of a high-sensitivity rapid diagnostic test for Plasmodium falciparum malaria in asymptomatic individuals from Uganda and Myanmar and naive human challenge infections. Am J Trop Med Hyg 97: 1540-1550.
15. Yukich J et al., 2017. Estimation of malaria parasite reservoir coverage using reactive case detection and active community fever screening from census data with rapid diagnostic tests in southern Zambia: a re-sampling approach. Malar J 16: 317.
16. Yukich JO et al., 2020. Cost-effectiveness of focal mass drug administration and mass drug administration with dihydroartemisinin-piperaquine for malaria prevention in Southern Province, Zambia: results of a community-randomized controlled trial. Am J Trop Med Hyg 103 (Suppl 2): 46-53.
17. Wanzira H, Kakuru A, Arinaitwe E, Bigira V, Muhindo MK, Conrad M, Rosenthal PJ, Kamya MR, Tappero JW, Dorsey G, 2014. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. Clin Infect Dis 59: 509-516.
18. Trape JF et al., 2014. The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. Lancet Infect Dis 14: 476-488.
19. Degefa T, Zeynudin A, Godesso A, Michael YH, Eba K, Zemene E, Emana D, Birlie B, Tushune K, Yewhalaw D, 2015. Malaria incidence and assessment of entomological indices among resettled communities in Ethiopia: a longitudinal study. Malar J 14: 24.
20. Simmons RA, Mboera L, Miranda ML, Morris A, Stresman G, Turner EL, Kramer R, Drakeley C, O'Meara WP, 2017. A longitudinal cohort study of malaria exposure and changing serostatus in a malaria endemic area of rural Tanzania. Malar J 16: 309.
21. Hamainza B, Moonga H, Sikaala CH, Kamuliwo M, Bennett A, Eisele TP, Miller J, Seyoum A, Killeen GF, 2014. Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers. Malar J 13: 128.
22. Finn TP et al., 2020. Adherence to mass drug administration with dihydroartemisinin-piperaquine and Plasmodium falciparum clearance in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 37-45.